» Articles » PMID: 16197366

Effects of Angiotensin-converting-enzyme Inhibitors in Combination with Diuretics on Blood Pressure and Renal Injury in Nitric Oxide-deficiency-induced Hypertension in Rats

Overview
Journal Clin Sci (Lond)
Date 2005 Oct 4
PMID 16197366
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The present study investigates the effects of chronic administration of ACEIs (angiotensin-converting-enzyme inhibitors; either zofenopril or enalapril) in combination with a diruetic (hydrochlorothiazide) on BP (blood pressure) increase and renal injury induced by L-NAME (NG-nitro-L-arginine methyl ester), an inhibitor of NO (nitric oxide) synthesis. Rats were untreated or received L-NAME alone, L-NAME+zofenopril+hydrochlorothiazide or L-NAME+enalapril+hydrochlorothiazide for 8 weeks. L-NAME treatment resulted in marked elevation in BP and mortality. Treatment with either ACEI and diuretic prevented the increase in BP induced by L-NAME, reduced the death rate and improved excretory parameters. Renal injury in the L-NAME group was severe, but, in the groups treated with either ACEI and diuretic, glomerular and tubulointerstitial lesions were not observed and the intensity, number and size of vessels affected was reduced. However, the efficacy of zofenopril+diuretic was superior to that of enalapril+diuretic in reducing vascular alterations. Oxidative stress indices and the expression of NO synthase and nitrotyrosine were normalized by the treatments. In conclusion, the combined treatment of zofenopril or enalapril with hydrochlorothiazide completely prevented the development of arterial hypertension induced by L-NAME. Renal morphological and functional alterations in the hypertensive animals were also almost completely normalized, but the treatment with zofenopril+diuretic produced a more complete organ protection. The protective effect is related to an activation of endothelial NO synthase expression and to a normalization of the oxidative stress parameters due to the inhibition of angiotensin II.

Citing Articles

Moderate Effect of Flavonoids on Vascular and Renal Function in Spontaneously Hypertensive Rats.

Paredes M, Romecin P, Atucha N, OValle F, Castillo J, Ortiz M Nutrients. 2018; 10(8).

PMID: 30115889 PMC: 6115889. DOI: 10.3390/nu10081107.


Efficacy of zofenopril in combination with thiazide diuretics in patients with acute myocardial infarction: a pooled individual data analysis of four randomized, double-blind, controlled, prospective studies.

Borghi C, Omboni S, Reggiardo G, Bacchelli S, Degli Esposti D, Ambrosioni E Ther Clin Risk Manag. 2018; 14:1185-1190.

PMID: 30022831 PMC: 6042489. DOI: 10.2147/TCRM.S165629.


Beneficial Effects of Different Flavonoids on Vascular and Renal Function in L-NAME Hypertensive Rats.

Paredes M, Romecin P, Atucha N, OValle F, Castillo J, Ortiz M Nutrients. 2018; 10(4).

PMID: 29652818 PMC: 5946269. DOI: 10.3390/nu10040484.


Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.

Omboni S, Malacco E, Napoli C, Modesti P, Manolis A, Parati G Adv Ther. 2017; 34(4):784-798.

PMID: 28260186 PMC: 5406448. DOI: 10.1007/s12325-017-0497-8.


End-organ protection in hypertension by the novel and selective Rho-kinase inhibitor, SAR407899.

Lohn M, Plettenburg O, Kannt A, Kohlmann M, Hofmeister A, Kadereit D World J Cardiol. 2015; 7(1):31-42.

PMID: 25632317 PMC: 4306204. DOI: 10.4330/wjc.v7.i1.31.